Combination lowers bleeding risk for bypass patients

02/28/2013 | Healio

Giving tranexamic acid with the anticoagulant clopidogrel before coronary artery bypass surgery was linked with lower odds of bleeding as well as improved platelet function, according to a study in the journal JAMA Surgery. Preoperative clopidogrel by itself was associated with increased bleeding risk and greater need for transfusions. "This extra protection [provided by tranexamic acid] against impaired platelet function improved the bleeding and transfusion outcomes in patients with clopidogrel persistence to a comparable level as that in patients with clopidogrel cessation," according to the study.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC